Mel Krajden
Advanced in Primary T Cell Immunodeficiency

Mel Krajden

655 West 12 Avenue, V5Z 4R4, 
Vancouver, BC, CA 
Advanced in Primary T Cell Immunodeficiency
655 West 12 Avenue, V5Z 4R4, 
Vancouver, BC, CA 
OverviewLocationsClinical Research

Overview

Mel Krajden practices in Vancouver, Canada. Mr. Krajden is rated as an Advanced expert by MediFind in the treatment of Primary T Cell Immunodeficiency. His top areas of expertise are Hepatitis C, Hepatitis, Human Papillomavirus Infection, Endoscopy, and Liver Transplant.

His clinical research consists of co-authoring 281 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Primary T Cell Immunodeficiency.

Gender
Male

Locations

655 West 12 Avenue, V5Z 4R4, Vancouver, BC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1, Randomized, Observer-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Immunogenicity of the bacTRL-Spike Oral Candidate Vaccine for the Prevention of COVID-19 in Healthy Adults
A Phase 1, Randomized, Observer-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Immunogenicity of the bacTRL-Spike Oral Candidate Vaccine for the Prevention of COVID-19 in Healthy Adults
Enrollment Status: Completed
Publish Date: October 25, 2022
Intervention Type: Biological
Study Drug: bacTRL-Spike Vaccine
Study Phase: Phase 1

281 Total Publications

Quadrivalent HPV Vaccine Evaluation Study with Addition of the Nonavalent Vaccine (QUEST-ADVANCE): protocol of an observational cohort study.
Quadrivalent HPV Vaccine Evaluation Study with Addition of the Nonavalent Vaccine (QUEST-ADVANCE): protocol of an observational cohort study.
Journal: BMJ open
Published: September 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Krajden's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile